A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease.
Phase 1/2 study testing ER2001 in Huntington's disease.
Active, not recruitingPhase 1 / Phase 2DrugClinicalTrials.govTreatment trial
Recruiting in: Chengdu, Guangzhou, China
Sponsor: ExoRNA Bioscience
Preparing a short plain-English summary.